First Trust Exchange Traded Fund Nyse Arca Biotechnology Index Fund Newsroom

Alkermes Analyst Ratings

BenzingaJul 25 06:38 ET · Ratings

United Therapeutics Analyst Ratings

BenzingaJul 25 06:26 ET · Ratings

Catalyst Sells Canadian Rights to Duchenne Drug to Kye Pharma

Seeking AlphaJul 24 14:22 ET

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

BenzingaJul 24 13:26 ET

AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday

BenzingaJul 24 10:46 ET

Alkermes Q2 2024 Earnings Preview

Seeking AlphaJul 23 13:36 ET

Notable Earnings Before Wednesday's Open

Seeking AlphaJul 23 10:48 ET

Here's How Much $1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today

BenzingaJul 22 17:30 ET

Executive Reshuffles: Otis Worldwide, HSBC and Rockwell Automation in Focus

Seeking AlphaJul 19 14:40 ET

Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights

BenzingaJul 17 13:00 ET

Exact Sciences Analyst Ratings

BenzingaJul 17 12:01 ET

Most Shorted S&P 500 Stocks in June

Seeking AlphaJul 17 09:52 ET

J&J Beats in Q2 as Pharma Segment Outperforms

Seeking AlphaJul 17 07:16 ET

Incyte, Moderna Among Most Shorted S&P 500 Healthcare Stocks in June

Seeking AlphaJul 16 13:01 ET

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $28,000 Today

BenzingaJul 16 10:30 ET

What 13 Analyst Ratings Have To Say About Halozyme Therapeutics

BenzingaJul 16 08:00 ET

Halozyme Therapeutics Analyst Ratings

BenzingaJul 16 07:44 ET

Genmab Upgraded at RBC on Valuation

Seeking AlphaJul 15 17:08 ET

6 Analysts Assess Alkermes: What You Need To Know

BenzingaJul 15 17:00 ET

What 8 Analyst Ratings Have To Say About Genmab

BenzingaJul 15 13:00 ET